This message was sent to ##Email##
|
|
|
|
|
| |
ADAA
 April 5-8, 2018
Treatment-Resistant Anxiety and Depression: Challenges and Opportunities
Washington Marriott Wardman Park Hotel
Register today to take advantage of early bird rates!
 Conference Announcement!
4th Annual Clinical Symposium — "Emotion Regulation Treatment in Action"
Friday, April 6 | 1 - 3 p.m.
Presenters:
Matthew McKay, PhD, The Wright Institute
Rochelle Frank, PhD, Private Practice & University of California, Berkeley
Moderator:
Patricia E. Zurita-Ona, PsyD, East Bay Behavioral Center
More information coming soon!
ADAA
 What is #GivingTuesday?
#GivingTuesday is a global day dedicated to giving back to your community. It is celebrated on the Tuesday following Thanksgiving (in the U.S.) and the widely recognized shopping events Black Friday and Cyber Monday.
With the holiday season around the corner, it is the perfect time to reflect on all that you are thankful for and to give back to organizations you support. This #GivingTuesday (Nov. 28), please support ADAA and our mission. Donating to ADAA helps us improve patient care by promoting implementation of evidence-based treatments and best practices across disciplines through continuing education and trainings and accelerating dissemination of research into practice.
Click here to support ADAA.
ADAA
 Members in the News
11/13/2017 Why Anxiety Is Especially Difficult for a Woman, Livestrong.com, Karen Cassiday, PhD
11/10/2017 Pediatric OCD: A Brief Family Therapy Module Reduces Symptom Severity, Psychiatry Advisor, Tara S. Peris, PhD
11/08/2017 An Update on the Relationship Between the Gut Microbiome and Obsessive-Compulsive Disorder, Healio, Beth Patterson, BscN, Michael Van Ameringen, MD, FRCPC, Jasmine Turna, BSc, PhD
Have you published a new book or research article? Have you been quoted in a recent news article/story? Please let us know so we can share your news with your ADAA colleagues! Simply email Lise Bram and we'll make sure to feature your news here every week and on the ADAA Members in the News website page.
ADAA Clinical Fellows Program
Welcome to our newest ADAA Clinical Fellows:
- Luana Marques, PhD, Harvard Medical School and Massachusetts General Hospital
- Marika Kyrimis, PhD, Private Practice, Seattle, WA
The Clinical Fellows Program advances ADAA's mission of improving patient outcomes through education and training of clinicians from all disciplines. The program offers participants an exclusive opportunity to further their clinical training in anxiety, depression and related disorders through participation in CE at the annual conference, and online through webinars and group consultations. A certificate signifies a specialization in anxiety and depression and a level of competency to the public and to referring clinicians.
An exclusive benefit for ADAA's clinical members, the Clinical Fellows Program provides participation in unique professional development activities, and demonstrates a commitment to lifelong learning and to providing quality patient care.
Additional Clinical Fellows Program Benefits Include:
- Special designation in the ADAA Find-a-Therapist online directory
- Recognition on the ADAA website
- Certificate for framing and the Clinical Fellows logo for professional use
- Acknowledgement on your ADAA Conference badge
Requirements:
- Licensed in state of practice and proof of current malpractice insurance
- Signed ethics statement, minimum of 5 years in practice and 3 years continuous ADAA Professional Membership
- Participation in 24 hours of ADAA professional education activities within two years of program registration (registration at the ADAA Conference fulfills that requirement)
- Participation in 12 hours of ADAA professional education activities every two years to maintain status
*While ADAA reserves the right to audit CE activities at any time, Clinical Fellows are expected to self-certify.
Learn more about becoming a Clinical Fellow
Meet ADAA's Clinical Fellows
New ADAA Public Webinar
ADAA's Public Education Committee offers free monthly webinars to address some of the most frequently asked questions about psychological and pharmacological treatment of anxiety disorders, depression, and related disorders for adults as well as children. Mental health professionals are welcome to listen and encouraged to share these webinars with their clients, but please note that this webinar series is intended for the general public. Continuing education credits are not available for this webinar series.
Depression and Heart Disease: Chicken and the Egg, and What You Can Do
presented by: Valerie Hoover, PhD (Division of Cardiovascular Medicine at Stanford University, School of Medicine.
ADAA
 ADAA's Professional Education Committee is inviting ADAA members and non-members who have participated in ADAA's educational programs to participate in a five-minute online needs assessment survey. The survey's focus is to gather feedback about ADAA's current professional education portfolio, to help us learn more about where professionals "go" to learn, to determine what is most important to you when choosing a continuing education program and to help us further enhance our professional education portfolio. You can take the survey here. We greatly appreciate your response by November 30th as it will help us ensure that ADAA is meeting your professional education needs! Thank you.
ADAA
(CE credits are approved by APA, NBCC and New York State Education Department's State Board for Social Work)
Timely Topic Webinar Series
Depression and Bipolar Disorder
OCD
Co-Occurring Disorders
Pharmacology
- May 10, 2018 OCD and Medication Management. Registration coming soon.
Career Development
Alternative Therapies
Learn more about all upcoming webinars and register today!
Missed a recent live webinar? Not to worry. ADAA offers our members and the professional community at large the opportunity to watch all webinars and receive CEs. View all available recorded webinars.
ADAA
Depression and Anxiety, the official journal of the Anxiety and Depression Association of America, is available online. ADAA members can subscribe at no charge. The journal welcomes original research and synthetic review articles covering neurobiology (genetics and neuroimaging), epidemiology, experimental psychopathology, and treatment (psychotherapeutic and pharmacologic) aspects of mood and anxiety disorders, and related phenomena in humans.
Learn more about the Journal.
| | RESEARCH AND PRACTICE NEWS |
HealthDay News
Having a father with depression may put teens at a heightened risk for the mental health problem, a new study suggests. Previous research had linked depression in mothers and in their children. But according to the investigators, this is the first study to find such an association between fathers and their children, independent of whether the mother has depression.
READ MORE
Psych Central
In the largest research study of its kind to date, researchers have determined cognitive behavioral therapy provides lasting benefits for children with obsessive compulsive disorder. In the study, investigators found that children and adolescents who benefited from the therapy were also free of patterns of compulsive behavior and compulsive thoughts one year after the treatment ended.
READ MORE
Psychiatry Advisor
According to the results of a study published in European Psychiatry, comorbid anxiety disorders among patients with depression or bipolar disorder were not associated with suicide attempts. In a two-year prospective study, researchers evaluated 667 participants with major depression or bipolar disorder for suicide attempts, depression and anxiety at 3, 12 and 24 months.
READ MORE
Medical News Today
Many people diagnosed with a form of cancer also experience post-traumatic stress disorder, and for some, this persists and sometimes worsens with time, even after successful cancer treatment. It may come as no surprise, then, that many people diagnosed with cancer also develop PTSD, according to a new study published in the journal Cancer.
READ MORE
Monthly Prescribing Reference
The Food and Drug Administration (FDA) has cleared Nexstim's "NBT" system, a non-invasive brain stimulation system, for the treatment of major depressive disorder. The NBT system uses a method of transcranial magnetic stimulation known as navigated TMS which allows for reproducible stimulation of specific areas of the brain.
READ MORE
| |
MISSED AN ISSUE OF ANXIETY AND DEPRESSION INSIGHTS? VISIT AND SEARCH THE ARCHIVE TODAY. |
Medical Xpress
Researchers using MRI have discovered a common pattern of structural abnormalities in the brains of people with depression and social anxiety, according to a study presented being next week at the annual meeting of the Radiological Society of North America (RSNA).
READ MORE
USA Today
The U.S. Food and Drug Administration has approved a pill that has a digital ingestion tracking system which can tell if medication was ingested by a patient. The Otsuka Pharmaceutical Co Ltd's Abilify MyCite tablets are the first drug with a digital ingestion tracking system to be approved in the U.S., according to a statement from the FDA.
READ MORE
Pharmacy Practice News
The FDA approved a new indication for cariprazine (Vraylar, Allergan) for the maintenance treatment of adults with schizophrenia. Cariprazine is already approved in the United States in adults for the acute treatment of schizophrenia and acute treatment of manic episodes of bipolar I disorder.
READ MORE
Psychiatry Advisor
Worse general health and increased depression severity in children with early childhood adverse experiences were shown to be correlated with sequential smaller inferior frontal gyrus volumes and poor emotional awareness, according to the results of a study published in JAMA Pediatrics.
READ MORE
HealthDay News
A spike in the amount of time teenage girls in the United States spend online is a likely culprit behind the surge in rates of depression, suicide and contemplation of suicide, new research suggests. The finding stems from an analysis of fatal injury data collected between 1999 and 2015 by the U.S. Centers for Disease Control and Prevention, as well as two large ongoing surveys that have been tracking American teens.
READ MORE
USA Today
People with a history of "self-mutilation," bipolar disorder, depression and drug and alcohol abuse can now seek waivers to join the Army under an unannounced policy enacted in August, according to documents. The decision to open Army recruiting to those with mental health conditions comes as the service faces the challenging goal of recruiting 80,000 new soldiers through September 2018.
READ MORE
The Huffington Post
When Connie Chow of Edmonton, Alta., couldn't access a therapist to help her through postpartum depression, her husband suggested she try online therapy. "I was isolating myself," recalls Chow. "He noticed that I didn't want to leave the house with the baby and that I would worry or fixate on sleep and breastfeeding. I didn't eat or care to shower much. I had thoughts of self-harm from not being a good mom.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
